| Value | ₹369.3 Cr |
|---|
BSE filing, NSE: KOVAI. Summary written from the filing by ALFA Finder's alert engine.
Kovai Medical Center and Hospital Ltd: key numbers
- Share price
- ₹5,834.50
- Market cap
- ₹6,384 Cr
- Revenue (annual)
- ₹1,586 Cr
- Net profit (annual)
- ₹244.5 Cr
- P/E (TTM)
- 25.3×Sector 52.0×
- Promoter holding
- 56.53%+0.01% QoQ
- FII holding
- 1.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kovai Medical Center and Hospital Ltd
All →Kovai Medical Center and Hospital Legal & Regulatory
Kovai Medical Center received a customs adjudication order for ₹2.11 Crore duty, fine and penalty. The order concerns non-fulfilment of post-importation conditions on duty-free equipment imports.
- Value
- ₹2.11 Cr
Kovai Medical Center and Hospital Board Meeting Date
Kovai Medical Center intimated BSE that its Board will meet on 11 Nov 2026 to approve unaudited results for the quarter ended 30 Sep 2026. No financial figures or other decisions are disclosed yet.
Kovai Medical Center and Hospital Other Announcement
Kovai Medical Center & Hospital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This is a routine periodic regulatory disclosure with no new transaction.
Kovai Medical Center and Hospital Promoter Buying: ₹0.19 Cr
Promoter Pavai Property Developers acquired 316 shares of Kovai Medical Center via open market purchase for ₹0.19 Crore. This increases their holding slightly.
- Value
- ₹0.19 Cr
Kovai Medical Center and Hospital Promoter Buying: ₹0.31 Cr
Promoter entity Pavai Property Developers Private Limited purchased 500 equity shares of Kovai Medical Center & Hospital Ltd via market acquisition.
- Value
- ₹0.31 Cr
Kovai Medical Center and Hospital Annual General Meeting
Kovai Medical Center shareholders approved Dr. Arun N Palaniswami's re-designation as Joint Managing Director via postal ballot. The resolution passed with 96% assent in September 2026.
Other debt & borrowing announcements
All →Shriram Finance Debt & Borrowing: ₹6.75 Cr
Shriram Finance paid Rs 6.75 Crore of interest on its NCDs on 29 October 2026, on time. This is a Regulation 57 confirmation of a debt servicing payment.
- Value
- ₹6.75 Cr
Satin Creditcare Network Debt & Borrowing: ₹1.28 Cr
Satin Creditcare paid monthly interest of Rs.1.28 Crore on two NCD series. Payments were made on October 29, 2026, ahead of the October 30 due date.
- Value
- ₹1.28 Cr
Mangalore Refinery And Petrochemicals Debt & Borrowing
Mangalore Refinery set 29 December 2026 as the record date for 13 January 2027 NCD interest. Payment covers the 7.40% coupon for the year.
- Execution
- 13 January 2026 to 12 January 2027 (interest period)
Aavas Financiers Debt & Borrowing: ₹22.3 Cr
Aavas Financiers certified timely half-yearly interest payment of ₹22.30 Crore on its NCDs (ISIN INE216P07241). No redemption payment was made during the period.
- Value
- ₹22.30 Cr
Black Buck Debt & Borrowing: ₹40 Cr
BlackBuck's board approved a ₹40 Crore corporate guarantee to Axis Bank securing a term loan for subsidiary Blackbuck Finserve. No immediate financial impact on the company.
- Value
- ₹40.00 Cr
Neogen Chemicals Debt & Borrowing: ₹1.69 Cr
Neogen Chemicals paid monthly interest of ₹1.69 Crore on its ₹200 Cr NCDs (ISIN INE136S07013) on 28 Oct 2026, fulfilling its Reg 57(1) obligation.
- Value
- ₹1.69 Cr